What is the Future of Targeted Biopsies in Cancer Care?
The future of targeted biopsies is promising, with ongoing advancements in imaging technologies and biopsy techniques. Emerging methods such as liquid biopsies, which analyze circulating tumor DNA in blood samples, may complement traditional tissue biopsies, offering a less invasive means of monitoring cancer. Additionally, artificial intelligence and machine learning are being integrated into imaging and biopsy processes to further enhance precision and diagnostic capabilities.
